Remisión sintomática y recuperación funcionalen pacientes que padecen esquizofrenia

Salud Mental

Volumn 37, Issue 1, 2014, Pages 59-74

  Valencia, Marcelo ^a   Caraveo, Jorge ^a   Colin, Ricardo ^b   Verduzco, Wazcar ^c   Corona, Fernando ^d  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d HOSPITAL PSIQUIÁTRICO FRAY BERNARDINO ÁLVAREZ   (Mexico)

Author keywords

Functional recovery; Psychosocial functioning; Symptomatic remission; Symtomatology

Indexed keywords

EID: 84896760115     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: 10.17711/sm.0185-3325.2014.008     Document Type: Article

References (151)

1. Lieberman J, Stroup S, McEvoy JP, Swartz M et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England J Medicine 2005;353(12):1209-1223.
2. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002;63(12):1121-1128.
3. Mueller N. Mechanism of relapse prevention in schizophrenia. Pharmacopsychiatry 2004;37(Supl 2):S141-S147.
4. Mccann TV, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J Psychiatr Ment Health Nurs 2008;15:622-629.
5. Torgalsboen AK, Rishov B. Maintenance of recovery from schizophrenia at 2'-year follow-up: what happened?. Psychiatry 2010;73(1):70-83.
6. Slade M, Amering M, Oades L. Recovery: an international perspective. Epidemiologia e Psichiatria Sociale 2008;17(2):128-137.
7. Lambert M, Schimmelmann BG, Naber D, Schacht A et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006;67:1690-1697.
8. van Os J, Drukker M, Campo J, Meijer J et al. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006;163:2000-2002.
9. Stahl S, Buckley P. Negative symptoms of Schizophrenia: a problem that will not go away. Acta Psychiatr Scand 2007;7:6-11.
10. Asociación Psiquiátrica Americana, DSM-IV. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Barcelona: Masson, SA; 1995.
11. Mueser K. Cognitive functioning, social adjustment and long-term outcome in schizophrenia. Cognition in schizophrenia. Tonmoy Sharma T, Harvey Ph(ed). Oxford University Press: 2000.
12. Rossler W, Haug HJ, Jorgensen PM. The psychosocial basis of schizophrenia Acta Psychiatr Scand 2000;102(Supl.407):1-99.
13. Bellack A, Mueser K. Psychosocial treatment for schizophrenia. Schizophr Bull 1993;19:317-336.
14. Lehman A, Kreyenbuhl J, Buchanan R et al. The Schizophrenia patient outcomes research team (PORT): Updated treatment Recommendations 2003. Schizophr Bull 2004;30(2):197-217.
15. Valencia M, Rascón ML, Juárez F, Murow E. A psychosocial skills training approach in Mexican out-patients with schizophrenia. Psychol Med 2007;37:1393-1402.
16. Liberman RP. Recovery from disability Manual of Psychiatric Rehabilitation. Washington, DC: American Psychiatric Publishing, Inc; 2008.
17. Valencia M, Rascón ML, Juárez F, Escamilla R et al. Application in Mexico of psychosocial rehabilitation with schizophrenia patients. Psychiatry 2010;73(3):248-263.
18. Mueser KT, Deavers F, Penn DL, Cassisi JE. Psychosocial treatments for Schizophrenia. Annual Review Clinical Psychology 2013;9:465-497.
19. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 1997;154 (supl. abril):1-63
20. Torrey W, Drake R, Dixon L, Burns B et al. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv 2001;52(1):45-50.
21. Bustillo J, Lauriello J, Horan W, Keith S. The psychosocial treatment of schizophrenia: an update. Am J Psychiatry 2001;158:163-175.
22. Thornicroft G, Susser E. Evidence-based psychotherapeutic interventions in the community care of schizophrenia. Br J Psychiatry 2001;178:2-4.
23. Lehman A, Steinwachs D. Evidence-based psychosocial treatment practice in schizophrenia: Lessons from the patient outcomes research team (PORT) project. J American Academy Psychoanalysis Dynamic Psychiatry 2003;31(1):141-154.
24. Falloon I, Montero I, Sungur M, Mastroeni A et al. Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment. World Psychiatry 2004;3(2):104-109.
25. McGurk SR, Mueser KT, DeRosa J, Wolfe R. Work, recovery, and comorbidity in schizophrenia: A randomized controlled trial of cognitive remediation. Schizophr Bull 2009;35(2):319-335.
26. Shean DG. Evidence-based psychosocial practice and recovery from schizophrenia. Psychiatry 2009;72(4):307-320.
27. Dixon L, Dickerson F, Bellack A. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010;36(1):48-70.
28. Liberman R, Kopelowicz A. Recovery from schizophrenia: A concept in search of research. Psychiatr Serv 2005;56(6):735-742.
29. Kruger A. Schizophrenia: Recovery and hope. Psychiatric Rehabilitation J 2000;24(1):29-37.
30. Nasrallah H. Is Schizophrenia recovery a myth? Curr Psychiatry 2008;7:5:19-20.
31. Martens W. Recovery from schizophrenia: Fact or fiction? Long-term remission is unusual, but comprehensive therapy may improve the odds. Curr Psychiatry 2004;3(7):19-30.
32. Andreasen N, Carpenter W, Kane J. Remission in schizophrenia: Proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441-449.
33. Tohen M, Strakowski SM, Zarate C, Hennen J et al. The McLean- Harvard first-episode project: 6- month symptomatic and functional outcome in affective and non-affective psychosis. Biol Psychiatry 2000;48(6):467-476.
34. Kane J. An evidence-based strategy for remission in schizophrenia. J Clin Psychiatry 2008;69(Supl 3):25-30.
35. Harrison G, Hopper K, Craig T. Recovery from psychotic illness: a 15 -and 25 year international follow-up study. Br J Psychiatry 2001;178:506-517.
36. Spaniol L, Wewiorski N, Gagne C, Anthony WA. The process of recovery from schizophrenia. Int Rev Psychiatry 2002;14(4):327-336.
37. Resnick S, Rosenheck R, Lehman A. An exploratory analysis of correlates of recovery. Psiquiatr Serv 2004;55(5):540-547.
38. Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull 2009;35(2):300-306.
39. Yeomans D, Taylor M, Currie A, Whale R. Resolution and remission in schizophrenia: getting well and staying well. Advances Psychiatric Treatment 2010;16:86-95.
40. Kay S, Fiszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
41. Overall JE, Gorham OR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
42. Andreasen NC, Olsen S. Negative and positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-794.
43. Leucht S, Davis J, Engel R et al. Definitions of response and remission in schizophrenia: recommendations for their use and their presentations for their use and their presentation. Acta Psychiatr Scand 2009;119(supl.438):7-14.
44. Leucht S, Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006;39:161-170.
45. Leucht S, Davis J, Engel R, Kane JM et al. Defining response in antipsychotic drug trials: Recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007;32:1903-1910.
46. van Os J, Cavallaro R, Leucht S, Peuskens J et al. Standardized remission criteria in schizophrenia Acta Psychiatr Scand 2006;113:91-95.
47. Wang L, Liu W, Van H. A comparative trial of the efficacy of olanzapine and chlorpromazine in treatment resistant schizophrenia. J Health Psychology 2004;12:203-204.
48. Figueira ML, Brissos S. Measuring psychosocial outcomes in schizophrenia patients. Curr Op Psychiatry 2011;24:90-99.
49. Emsley R, Chiliza B, Asmal L, Lehloenya K. The concepts of remission and recovery in schizophrenia. Curr Op Psychiatry 2011;24:114-121.
50. Weiden P, Zygmunt A. Medication noncompliance in schizophrenia: part I. Assessment J Practice. Psychiatry Behavioral Health 1997;3:106-110.
51. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry 2004;161(2):2-56.
52. Davidson L, Roe D. Recovery from versus recovery in serious mental illness: one strategy for lessening plaguing recovery. J Mental Health 2007;16:1-12.
53. Davidson L, O'Connell M, Tondora J, Styron T et al. The top ten concerns about recovery encountered in mental health system transformation. Psychiatr Serv 2006;57(5):640-645.
54. Harrow M, Grossman LS, Jobe TH, Herbener ES. Do patients with schizophrenia ever show periods of recovery? A 15-year multi-followup study. Schizophr Bull 2005;31(3):723-734.
55. Schrank B, Slade M. Recovery in psychiatry. Psychiatric Bull 2007;31: 321-325.
56. Whitehorn D, Brown J, Richard, Rui Q et al. Multiple dimensions of recovery in early Psychosis. Int Rev Psychiatry 2002;14(4):273-283.
57. Harding CM, Brooks GW, Ashikaga T et al. The Vermont longitudinal study of persons with severe mental illness: II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144:727-735.
58. Torgalsboen AK. Full recovery from schizophrenia: The prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender. Psychiatry Res 1999;88:142-152.
59. Bobes J, Ciudad A, Álvarez E, San L et al. Recovery from schizophrenia: results from a 1-year follow-up pbservational study of patients in symptomatic remission. Schizophr Res 2009;115:58-66.
60. San L, Ciudad A, Álvarez E, Bobes J et al. Symptomatic remission and social/ vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study. Eur Psychiatry 2007;22:490-498.
61. Asociación Psiquiátrica Americana, DSM-IV. Escala de evaluación de la actividad global- EEAG-GAF. Manual Diagnóstico y Estadístico de los Trastornos Mentales. Barcelona: Masson, SA; 1995.
62. Kopelowicz A, Liberman RP, Ventura J, Zarate R et al. Neurocognitive correlates of recovery from schizophrenia. Psychol Med 2005;35:1165-1173.
63. Stephens JH, Richard P, McHugh PR. Long-term follow-up of patients hospitalized for schizophrenia, 1913-1940. J Nervous ental Disease 1997;185:715-721.
64. Kiriakakis V, Bhatia HP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998;121(11):2053-2066.
65. Mala E. Early onset schizophrenia. Czek Psychiatry 1993;89(5):259-271.
66. Modestin J, Huber A, Satiri E, Malti T et al. Long-term course of schizophrenia illness: Bleuler's study reconsidered. Am J Psychiatry 2003;160:2202-2208.
67. Fresan A, Apiquian R, Loyzaga C et al. Recuperación funcional en el primer episodio psicótico. Psiquiatría Salud Integral 2002;marzo/abril:40-44.
68. Valencia M, Rojas E, González C, Ramos L et al. Evaluación del funcionamiento psicosocial en pacientes de un Centro de Salud. Salud Pública México 1989;31(5):674-687.
69. Valencia M, Juarez F, Ortega H. Integrated treatment to achieve functional recovery for first-episode psychosis. Schizophrenia Research Treatment 2012; DOI(10.1155).
70. Valencia M, Fresan A, Juárez F, Escamilla R et al. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia. J Psychiatric Research 2013 (en prensa).
71. Song LY, Shih CY. Factors process and outcomes of recovery from psychiatric disability: the unity model. Int J Soc Psychiatr 2009;55(4):348-360.
72. Mausbach BT, Moore R, Bowie C. A review of instruments for measuring functional recovery in those diagnosed with psychosis. Schizophr Bull 2009;35:307-318.
73. Kern RS, Glynn SM, Horan WP, Marder S. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr Bull 2009;35(2):347-361.
74. Lysaker PH, Glyin SM. Psychotherapy and recovery from schizophrenia. Psychol Serv 2010;7:75-91.
75. Shrivastava A, Johnston M, Shah N, Bureau Y. Redefining measures in schizophrenia: integrating social and clinical parameters. Curr Op Psychiatry 2010;23:120-126.
76. Houghton J. Maintaining mental health in a turbulent world. Schizophr Bull 1982;8:548-552.
77. Leete E. How I perceive and manage my illness. Schizophr Bull 1989;15:197-198.
78. Unzicker R. On my own: A personal journey through madness and re-emergence. Psychosocial Rehabilitation J 1989;13:70-77.
79. Fenley G. Compliance and recovery. Clinical Schizophrenia Related Psychoses 2008;12(3):262-263.
80. Deegan PE. Recovery: the lived experience of rehabilitation. Psychosocial Rehabilitation J 1988;11:11-19.
81. Anthony W, Cohen M, Farkas M, Gagne C. Psychiatric rehabilitation. Segunda edición. Boston: Boston University; 2002.
82. Opler M, Yang LW, Caleo S, Alberti P. Statistical validation of criteria for symptom remission in schizophrenia: Preliminary findings. BMC Psychiatry 2007;7(35):1-7.
83. Farkas M. The vision of recovery today: what it is and what it means for services. World Psychiatry 2007;2(2):68-74.
84. Mueser K, Corrigan P, Hilton D et al. Illness management and recovery: A review of the research. Psychiatr Serv 2002;5:3-10.
85. O'Hagan M. Recovery in New Zealand: Lessons for Australia? Australian e-Journal Advancement Mental Health 2004;3(1):1-3.
86. Bellack A. Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications. Schizophr Bull 2006; 32(3):432-442.
87. National Institute for Mental Health in England. Emerging Best Practices in Mental Health Recovery. NIMHE: London. 2004.
88. Mueser K, Meyer P, Penn D, Clancy R, et al. The Illness Management and Recovery Program: Rationale, Development, and Preliminary Findings. Schizophr Bull 2006; 32(S1):S32-S43.
89. Glynn S, Cohen A, Dixon L, Niv N. The Potential Impact of the Recovery Movement on Family Interventions for Schizophrenia: Opportunities and Obstacles. Schizophr Bull 2006; 32(3):451-463.
90. Bleuler M. A 23- year longitudinal study of 208 schizophrenics and impressions in regard to the nature of Schizophrenia, in The Transmission of Schizophrenia. Edited by Rosenthal D, Kety SS. Pergamon, Oxford; 1968.
91. Tsuang M, Woolson RF, Fleming J. Long-term outcome of major psychoses: I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch Gen Psychiatry 1979;36(12):1295-1301.
92. Huber G, Gross G, Schuttler R, Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980;6:592-605.
93. Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606-618.
94. Ogawa K, Miya M, Watarai A, Nakazawa M et al. A long -term followup study ofschizophrenia in Japan with special reference to the course of social adjustment. Br J Psychiatry 1987;151:758-765.
95. Loebel AD, Lieberman JA , Alvir JM. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.
96. Hegarty JD, Baldessarini RJ, Tohen M. One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psychiatry 1994;151:1409-1416.
97. Lieberman J, Jody D, Geisler S et al. Time course and biological correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 1993;50:369-376.
98. DeSisto MJ, Harding CM, McCormick RV et al. The Maine and Vermont three decade studies of mental illness. II. Longitudinal course comparisons. Br J Psychiatry 1995;167:338-342.
99. McGorry PD, Edwards J, Mihalopoulos C et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305-326.
100. Edwards J, Maude D, MacGorry PD, Harrigan S et al. Prolonged recovery in first- episode psychosis. Br J Psychiatry 1996;172 (supl 33):107-116.
101. Hoffman H, Kupper Z. Facilitators of psychosocial recovery from schizophrenia. Int Rev Psychiatry 2002;14:293-302.
102. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A et al. symptomatic and functional recovery from a first-episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473- 479.
103. Haro JM, Novick D, Suarez D, Alonso J et al. and the SOHO study group. Remission and relapse in the outpatient care of schizophrenia three-year results from the schizophrenia outpatient health outcomes study. J Clinical Psychopharmacology 2006;26:571-578.
104. Hellding L, Kane JM, Karilampi U, Norlander T et al. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorder Schizophr Res 2007;93:160-168.
105. Holthausen EA, Wiersma D, Cahn W, Kahn RS et al. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res 2007;149:71-80.
106. Lambert M, Naber D, Schacht A, Wagner T et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand 2008;118:220-229.
107. Emsley R, Oosthuizen P, Koen L, Niehaus DJH et al. Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection. Int Clin Psychopharmacology 2008;23:325-331.
108. Addington J, Addinton D. Symptom remission in first episode patients. Schizophr Res 2008;106(2-3):281-285.
109. Eberhard J, Levander S, Lindström E. Remission in schizophrenia: analysis in naturalistic setting. Comp Psychiatry 2009;50:200-208.
110. Boter H, Peuskens J, Libiger J, Wolfgang W et al. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophr Res 2009;115:97-103.
111. Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull 2009;35(2):362-369.
112. Zimmermann J, Wolter A, Hannöver W, Krischke N. Frequency of remission in schizophrenia patients at one year follow-up. Psychiatrische Praxis 2009:36(4):182-188.
113. Potkin SG, Weiden PJ, Loebel AD, Warrington LE et al. Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol. Int J Neuropsychopharmacol 2009;12:1233-1248.
114. Rossi A, Bagalá A, Del Curatolo V, Scapati F et al. Remission in schizophrenia: one-year italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder. Human Psychopharmacology 2009;24(7):574-583.
115. Wobrock T, Köhler J, Klein P, Falkai P. Achieving symptomatic remission in out-patients with schizophrenia - a naturalistic study with quetiapine. Acta Psychiatr Scand 2009;120:120-128.
116. Henry LP, Amminger P, Harris MG. The EPPIC follow-up study of firsts-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J Clin Psychiatry 2010;71(6):716-728.
117. Peuskens J, Trivedi JK, Brecher M, Miller F. Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate: post-hoc analysis of data from a randomized withdrawal, placebo-controlled study. Int Clin Psychopharmacology 2010;25(3):183-187.
118. Lambert M, De Marinis T, Pfeil J, Naber D, et al. Establishing remission and good clinical functioning in schizophrenia: Predictors of best outcome with long-term risperidone long acting injectable treatment. Eur Psychiatry 2010;25:220-229.
119. Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, et al. Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients. Schizophr Res 2010;118(1-3):183-188.
120. Cassidy CM, Norman R, Manchanda R, Schmitz N et al. Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years. Schizophr Bull 2010:36(5):1001-1008.
121. Saravan B, Jacob KS, Johnson S, Prince M et al. Outcome of first-episode schizophrenia in India: longitudinal study of effect of insight and psychopathology. Br J Psychiatry 2010;196(6):454-459.
122. Li CT, Su TP, Chou YH, Lee YC et al. Symptomatic resolution among Chinese patients with schizophrenia and associated factors. J Formos Med Assoc 2010;109(5):378-388.
123. Wolter A, Preuss WU, Richard KN, Mooi WW et al. Remission, prediction and stability of symptoms in schizophrenia: a naturalistic 12-monthfollow-up study. Int J Psychiatr Clin Pract 2010;14(3):160-167.
124. Ciudad A, Bobes J, Álvarez E, San L et al. Clinical meaningful outcomes in schizophrenia: remission and recovery. Revista Psiquiatría Salud Mental 2011;4(1):53-65.
125. Schennach-Wolf R, Seemüller F, Obermeier M, Messer T et al. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders. Eur Psychiatry 2010; DOI(10.1016).
126. Brissos S, Videira V, Balanzá-Martinez V, Carita AI et al. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life and neurocognitive performance. Schizophr Res 2011; DOI(10.1016).
127. Ventura J, Subotnik K, Guzik LH, Hellmann GS et al. Remission and recovery during the first outpatient year of the early course of schizophrenia. Schizophr Res 2011;132:18-23.
128. Barak Y, Swartz M. Remission amongst elderly schizophrenia patients. Eur Psychiatry 2011; DOI(10.1016).
129. Faber G, Smid GOM H, Van Gool AR, Wunderink L et al. Neurocognition and recovery in first episode psychosis. Psychiatry Res 2011;188:1-6.
130. Levine SZ, Rabinowitz J, Ascher-Svanum H, Faries DE et al. Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study. Schizophr Res 2011;133:42-46.
131. Girgis RR, Phillips MR, Li X, Li K et al. Clozapine v. chlorpromazine in treatment-naive,first-episode schizophrenia. 9-year outcomes of a randomized clinical trial. Br J Psychiatry 2011;199:281-288.
132. Karow A, Moritz S, Lambert M, Schöttle D et al, on behalf of the EGOFORS initiative. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry 2012;27:401-405.
133. Verma S, Subramaniam M, Abdin E, Poon LY, et al. Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr Scand 2012;126:282-289.
134. Mosolov SN, Potapov AV, Ushakov UV. Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population. Ann Gen Psychiatry 2012;11(1):1-10.
135. Barak Y, Aizenberg D. Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment. BMC Psychiatry 2012;12(108):1-5.
136. Dahlan R, Midin M, Sidi H. Remission of symptoms among schizophrenia patients receiving assertive community treatment (ACT) in Malaysia: one year follow-up. Sains Malaysiana 2013;42:389-397.
137. Prikryl R, Kholova M, Prikrylova Kucerova H, Ceskova E. Prevalence of remission and recovery in schizophrenia in the Czech Republic. Comp Psychiatry 2013; DOI(10.1016).
138. Cannavó D, Concerto C, Battaglia E, Bianchini O et al. Insight and recovery in schizophrenic patients: an observational study. Clinical Neuropsychopharmacology 2013;23(1):S83-S84.
139. Marneros A, Deister A, Rohde A et al. Long-term outcome of schizoaffective and schizophrenic disorders, a comparative study, I: Definitions, methods, psychopathological and social outcome. Eur Arch Psychiatry Clin Neurosc 1989;238:118-125.
140. Kobayashi T. Course types of first admission schizophrenia. Seishin Igaku Clinical Psychiatry 2002;44(2):161-168.
141. Warner R. Recovery from schizophrenia: psychiatry and political economy. 3rd ed. Hove, UK: Brunner-Routledge; 2004.
142. Menezes NM, Arenovich T, Zipursky RB. A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol Med 2006;36(10):1349-1362.
143. Miettunen J, Veijola J, McGrath J, Saha S et al. Recovery from schizophrenia a meta-analysis. Schizophr Res 2008;98:3-199.
144. Crumlish N, Whitty P, Clarke M, Browne S et al. Beyond the clinical period: longitudinal study of 8 year outcome in first-episode nonaffective psychosis. Br J Psychiatry 2009;194:18-24.
145. Strauss GP, Harrow M, Grossman LS, Rosen C. Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study. Schizophr Bull 2010;36(4):788-799.
146. Jobe T, Harrow M. Schizophrenia course, long-term outcome, recovery, and prognosis. Current Directions Psyhcological Science 2010;19:220- 225 y 2:2145-2155.
147. Bertelsen M, Jeppesen P, Petersen L, Thorup A et al. Course of illness in a sample of 265 patients with first-episode psychosis-five-year follow- up of the Danish opus trial. Schizophr Res 2009;107:173-178.
148. Abdel-Baki A, Lesage A, Nicole L, Cossette M et al. Schizophrenia, an illnes with bad outcome: myth or reality?. Clin J Psychiatry 2011;56(2):92-101.
149. Albert N, Bertelsen M, Thorup A, Petersen L et al. Predictors of recovery from psychosis analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res 2011;125:257-266.
150. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull 2012; DOI(10.1093).
151. Harrow M, Jobe TH, Faull RN. Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20- year longitudinal study. Psychol Med 2012;42:2145-2155.